(Q36028061)

English

A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

based on heuristic

inferred from title

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

author name string

Cuzick J

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Erskine S

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Edelman D

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Galton DA

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 May 1987

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

55

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

523-529

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Long-term survival in myelomatosis. A report to the MRC working party on leukaemia in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001731

2 October 2017

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001731

2 October 2017

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001731

2 October 2017

Acute Leukemia in Multiple Myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001731

2 October 2017

Acute Leukemia Following Prolonged Cytotoxic Agent Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001731

2 October 2017

Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001731

11 July 2018

The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001731

11 July 2018

Multiple myeloma and acute myelomonocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001731

23 September 2018

A method for analysing case-control studies with ordinal exposure variables

1 reference

https://pubmed.ncbi.nlm.nih.gov/3300761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosome studies in preleukemic states. IV. Myeloproliferative versus cytopenic disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/3300761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/3300761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/3300761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coexistent myelodysplasia and plasma cell neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3300761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)

1 reference

https://pubmed.ncbi.nlm.nih.gov/3300761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/3300761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Razoxane and leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3300761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1987.107

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36028061&oldid=2198087377"